Although New Jersey’s biopharmaceutical sector opposed H.R. 3, we share its overriding goal – to ensure that patients can access the treatments and cures that
From NJBIZ: The history of manufacturing in New Jersey is the history of manufacturing in America. Historians can trace the birth of the country’s political
HINJ President and Chief Executive Officer Dean J. Paranicas has issued the following statement about the full repeal of the medical device excise tax: “Patients,
HINJ honored Prof. Jay A. Tischfield of Rutgers University–New Brunswick today (Dec. 9, 2019) “in recognition of innovative and creative leadership in genetics research, scholarship
For the first time in human history, we have cured hepatitis C – the days of liver transplants and life-long treatments are fast disappearing. We
On Nov. 12, HINJ presented the 2019 Honorable Bob Franks Public Service Award to Joan Quigley, President/CEO of North Hudson Community Action Corporation (NHCAC). She
Steve Issenman
Senior V.P.
732-729-9621
issenman@hinj.org
